website: 86th General Session & Exhibition of the IADR

ABSTRACT: 3537  

Identification of genes related to radioresistance of oral cancer

K. FUSHIMI, K. UZAWA, T. ISHIGAMI, K. SAITO, K. SHIMADA, A. MURANO, M. NAKATSURU, K. OGAWARA, M. SHIIBA, and H. TANZAWA, Chiba University, Japan

Objectives: Radiation therapy has played an important role in controlling tumor growth in many patients with cancer. However, radiation therapy is sometimes ineffective, because cancer cells can be refractory to radiation therapy. The aim of the current study was to identify genes associated with radioresistant oral squamous cell carcinoma (OSCC).

Methods: We compared gene expression signatures between OSCC cell lines exhibiting radioresistance and cells with radiosensitivity after X-ray irradiation in a dose-dependent manner using Affymetrix GeneChip analysis with Human Genome-

U133 plus 2.0 GeneChip. The identified genes were analyzed using the Ingenuity Pathway Analysis Tool to investigate the functional network and gene ontology. Changes in mRNA expression in the genes were assessed by real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR).

Results: The microarray data identified 167 genes that were significantly overexpressed in radioresistant cells after X-ray irradiation. Among the genes identified, 40 were mapped to 3 highly significant genetic networks identified by the Ingenuity Pathway Analysis tool. Gene ontology analysis showed that cancer-related function had the highest significance. The 40 genes included 25 cancer-related genes that formed 1 network and were categorized by function into growth and proliferation, apoptosis, and adhesion. Furthermore, qRT-PCR showed that the mRNA expression levels of the 25 genes were higher in radioresistant cells than in radiosensitive cells in a dose-dependent manner and in a time-dependent manner.

Conclusion: Our results suggest that the identified genes help to elucidate the molecular mechanisms of the radioresistance of OSCC and could be radiotherapeutic molecular markers for choosing the appropriate radiotherapy for this disease.

Back to Top